Shares

8 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Feb 14, 2024

BUY
$4.7 - $9.87 $145,554 - $305,664
30,969 Added 158.01%
50,569 $331,000
Q3 2023

Nov 14, 2023

SELL
$9.14 - $12.85 $71,017 - $99,844
-7,770 Reduced 28.39%
19,600 $196,000
Q2 2023

Aug 14, 2023

BUY
$12.09 - $15.0 $66,337 - $82,305
5,487 Added 25.07%
27,370 $340,000
Q1 2023

May 15, 2023

BUY
$12.99 - $16.48 $284,260 - $360,631
21,883 New
21,883 $306,000
Q4 2021

Feb 14, 2022

SELL
$35.0 - $45.94 $785,750 - $1.03 Million
-22,450 Closed
0 $0
Q3 2021

Nov 15, 2021

BUY
$36.8 - $60.62 $402,702 - $663,364
10,943 Added 95.1%
22,450 $1.1 Million
Q2 2021

Aug 16, 2021

SELL
$32.46 - $45.0 $315,868 - $437,895
-9,731 Reduced 45.82%
11,507 $481,000
Q1 2021

May 17, 2021

BUY
$25.8 - $38.49 $547,940 - $817,450
21,238 New
21,238 $757,000

Others Institutions Holding MRVI

About MARAVAI LIFESCIENCES HOLDINGS, INC.


  • Ticker MRVI
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 131,540,000
  • Market Cap $723M
  • Description
  • Maravai LifeSciences Holdings, Inc., a life sciences company, provides products to enable the development of drug therapies, diagnostics, novel vaccines, and support research on human diseases in the United States and internationally. The company's products address the key phases of biopharmaceutical development and include nucleic acids for dia...
More about MRVI
Track This Portfolio

Track Man Group PLC Portfolio

Follow Man Group PLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Man Group PLC, based on Form 13F filings with the SEC.

News

Stay updated on Man Group PLC with notifications on news.